4Stiehl A;Rudolph G;Kloters-plachky P.Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid:outcome after endoscopic treatment[J],2002(02).
6European Association for the Study of the Liver.EASL Clinical Practice Guidelines:management of cholestatic liver diseases[J]Journal of Hepatology,2009(02):237-267.
7Chapman R;Fevery J;Kalloo A.Diagnosis and management of primary sclerosing cholangitis[J]Hepatology,2010(02):660-678.
8Lee YM;Kaplan MM;Practice Guideline Committee of the ACG.Management of primary sclerosing cholangitis[J]American Journal of Gastroenterology,2002(03):528-534.
9Moff SL;Kamel IR;Eustace J.Diagnosis of primary sclerosing cholangitis:a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography[J]Gastrointestinal Endoscopy,2006(02):219-223.
10Berstad AE;Aabakken L;Smith HJ.Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis[J]Clinical Gastroenterology and Hepatology,2006(04):514-520.
10Huang WD, Zhang J, Moore DD. A traditional herbal medicine en- i hanees hilirubin clearance by activating the nuclear receptor CAR. The Journal of clinical investigation , 2004( 1 ) : 137-143.
